Optimization and establishment of RNA interference-mediated knockdown of the progestagen-associated endometrial protein gene in human metastatic melanoma cell lines

Chai,Lina; Qiao,Zhixin; Wang,Jiexi; Liu,Minxia; Wang,Yan; Wang,Xuanlin; He,Min; Li,Weijing; Yu,Qun; Han,Ying; Ren,Suping

doi:10.3892/mmr.2013.1679

Optimization and establishment of RNA interference-mediated knockdown of the progestagen-associated endometrial protein gene in human metastatic melanoma cell lines

Authors:
- Lina Chai
- Zhixin Qiao
- Jiexi Wang
- Minxia Liu
- Yan Wang
- Xuanlin Wang
- Min He
- Weijing Li
- Qun Yu
- Ying Han
- Suping Ren
View Affiliations

Affiliations: Beijing Institute of Transfusion Medicine, Beijing 100850, P.R. China
Published online on: September 13, 2013 https://doi.org/10.3892/mmr.2013.1679
Pages: 1390-1396

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Progestagen‑associated endometrial protein (PAEP), also termed glycodelin, is a 28‑kDa glycoprotein of the lipocalin superfamily that is expressed in a variety of tumors, including gynecological tumors, lung cancer and melanoma. To determine the biological functions of the PAEP gene in tumor development and progression, the production of transient and stable PAEP knockdown cell models is required. In the present study, RNA interference technology was used to silence PAEP gene expression in melanoma and transfection was screened for and the conditions were optimized using fluorescence microscopy, flow cytometry, qPCR and western blot analysis. The results of the present study showed that the transient transfection of melanoma cells with 100 nmol/l PAEP siRNA or lentiviral PAEP small hairpin RNA (shRNA) [multiplicity of infection (MOI), 100 pfu/cell] efficiently knocked down target gene expression. To establish stable PAEP knockdown cell lines, melanoma cells were infected with a low MOI (10 pfu/cell) of lentiviral particles expressing PAEP shRNA. Following puromycin screening, the PAEP gene knockdown efficiency was demonstrated to be >80% in 624‑Mel and 624.38‑Mel cell lines, which was validated by western blot analysis. Therefore, melanoma cell lines with stable knockdown of PAEP were successfully established and may be used as effective cell models to study the biological functions of the PAEP gene in melanoma.

View Figures

View References

1	Seppälä M, Taylor RN, Koistinen H, Koistinen R and Milgrom E: Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev. 23:401–430. 2002.
2	Jeschke U, Kuhn C, Mylonas I, Schulze S, Friese K, Mayr D, Speer R, et al: Development and characterization of monoclonal antibodies for the immunohistochemical detection of glycodelin A in decidual, endometrial and gynaecological tumour tissues. Histopathology. 48:394–406. 2006. View Article : Google Scholar : PubMed/NCBI
3	Richter C, Baetje M, Bischof A, Makovitzky J, Richter DU, Gerber B, Briese V, et al: Expression of the glycodelin A gene and the detection of its protein in tissues and serum of ovarian carcinoma patients. Anticancer Res. 27:2023–2025. 2007.PubMed/NCBI
4	Hautala LC, Greco D, Koistinen R, Heikkinen T, Heikkilä P, Aittomäki K, Blomqvist C, et al: Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients. Breast Cancer Res Treat. 128:85–95. 2011. View Article : Google Scholar : PubMed/NCBI
5	Seppälä M, Koistinen H, Koistinen R, Hautala L, Chiu PC and Yeung WS: Glycodelin expression in reproductive endocrinology and hormone-related cancer. Eur J Endocrinol. 160:121–133. 2009.
6	Kunert-Keil C, Steinmüller F, Jeschke U, Gredes T and Gedrange T: Immunolocalization of glycodelin in human adenocarcinoma of the lung, squamous cell carcinoma of the lung and lung metastases of colonic adenocarcinoma. Acta Histochem. 113:798–802. 2011. View Article : Google Scholar : PubMed/NCBI
7	Ren S, Liu S, Howell PM Jr and Riker AI: Identification of a putative oncogene in human melanoma: progestagen-associated endometrial protein. Ann Surg Oncol. 15(Suppl 2): 102008.
8	Hautala LC, Koistinen R, Seppälä M, Bützow R, Stenman UH, Laakkonen P and Koistinen H: Glycodelin reduces breast cancer xenograft growth in vivo. Int J Cancer. 123:2279–2284. 2008. View Article : Google Scholar : PubMed/NCBI
9	Song M, Ramaswamy S, Ramachandran S, Flowers LC, Horowitz IR, Rock JA and Parthasarathy S: Angiogenic role for glycodelin in tumorigenesis. Proc Natl Acad Sci USA. 98:9265–9270. 2001. View Article : Google Scholar : PubMed/NCBI
10	Ren S, Liu S, Howell PM Jr, Zhang G, Pannell L, Samant R, et al: Functional characterization of the progestagen-associated endometrial protein gene in human melanoma. J Cell Mol Med. 14:1432–1442. 2010. View Article : Google Scholar : PubMed/NCBI
11	Gray-Schopfer V, Wellbrock C and Marais R: Melanoma biology and new targeted therapy. Nature. 445:851–857. 2007. View Article : Google Scholar : PubMed/NCBI
12	Fodstad O, Kjønniksen I, Aamdal S, Nesland JM, Boyd MR and Pihl A: Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells. Cancer Res. 48:4382–4388. 1988.
13	Pellitteri-Hahn MC, Warren MC, Didier DN, Winkler EL, Mirza SP, Greene AS and Olivier M: Improved mass spectrometric proteomic profiling of the secretome of rat vascular endothelial cells. J Proteome Res. 5:2861–2864. 2006. View Article : Google Scholar : PubMed/NCBI
14	Mbeunkui F, Metge BJ, Shevde LA and Pannell LK: Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer. J Proteome Res. 6:2993–3002. 2007. View Article : Google Scholar : PubMed/NCBI
15	Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, et al: Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer. Breast Cancer Res. 10:R222008. View Article : Google Scholar : PubMed/NCBI
16	Cummins DL, Cummins JM, Pantle H, Silverman MA, Leonard AL and Chanmugam A: Cutaneous malignant melanoma. Mayo Clin Proc. 81:500–507. 2006. View Article : Google Scholar
17	Riker AI, Enkemann SA, Fodstad O, et al: The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics. 1:132008. View Article : Google Scholar : PubMed/NCBI
18	Scholz C, Toth B, Barthell E, Mylonas I, Weissenbacher T, Friese K and Jeschke U: Glycodelin expression in correlation to grading, nodal involvement and steroid receptor expression in human breast cancer patients. Anticancer Res. 30:1599–1603. 2010.PubMed/NCBI
19	Mandelin E, Lassus H, Seppälä M, Leminen A, Gustafsson JA, Cheng G, Bützow R and Koistinen R: Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Cancer Res. 63:6258–6264. 2003.PubMed/NCBI
20	Uchida H, Maruyama T, Ono M, Ohta K, et al: Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. Endocrinology. 148:896–902. 2007. View Article : Google Scholar
21	Verdel A, Jia S, Gerber S, Sugiyama T, Gygi S, Grewal SI and Moazed D: RNAi-mediated targeting of heterochromatin by the RITS complex. Science. 303:672–676. 2004. View Article : Google Scholar : PubMed/NCBI
22	Yao MC, Fuller P and Xi X: Programmed DNA deletion as an RNA-guided system of genome defense. Science. 300:1581–1584. 2003. View Article : Google Scholar : PubMed/NCBI
23	Naldini L, Blömer U, Gage FH, Trono D and Verma IM: Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA. 93:11382–11388. 1996. View Article : Google Scholar : PubMed/NCBI
24	Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM and Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 272:263–267. 1996. View Article : Google Scholar : PubMed/NCBI
25	Sumimoto H and Kawakami Y: Lentiviral vector-mediated RNAi and its use for cancer research. Future Oncol. 3:655–664. 2007. View Article : Google Scholar : PubMed/NCBI
26	Sumimoto H and Kawakami Y: The RNA silencing technology applied by lentiviral vectors in oncology. Methods Mol Biol. 614:187–199. 2010. View Article : Google Scholar : PubMed/NCBI
27	Lawler PR and Lawler J: Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb Perspect Med. 2:a0066272012. View Article : Google Scholar : PubMed/NCBI
28	Jia L and Waxman DJ: Thrombospondin-1 and pigment epithelium-derived factor enhance responsiveness of KM12 colon tumor to metronomic cyclophosphamide but have disparate effects on tumor metastasis. Cancer Lett. 330:241–249. 2013. View Article : Google Scholar
29	Kim NH, Kim SN, Seo DW, Han JW and Kim YK: PRMT6 overexpression upregulates TSP-1 and downregulates MMPs: its implication in motility and invasion. Biochem Biophys Res Commun. 432:60–65. 2013. View Article : Google Scholar : PubMed/NCBI
30	Senger DR, Perruzzi CA and Papadopoulos A: Elevated expression of secreted phosphoprotein 1 (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res. 9:1291–1299. 1989.PubMed/NCBI
31	Das R, Philip S, Mahabeleshwar GH, Bulbule A and Kundu GC: Osteopontin: it’s role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression. IUBMB Life. 57:441–447. 2005.
32	Wu Y, Jiang W, Wang Y, Wu J, Saiyin H, Qiao X, Mei X, et al: Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression. PLoS One. 7:e429762012. View Article : Google Scholar : PubMed/NCBI